ArteMedicale
ActiveSummary
ArteMedicale has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54k and a net result of €54k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
65
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability57▼-43
Solvency39▼-42
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity short (current ratio 0.98 against 1.44 in 2024; short-term debt: 85.9% and cash: 71.7% of total assets), and 85.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 29-10-2025, 2 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
2 d early
2024
1 d early
2023
4 d early
2022
7 d late
2021
19 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close24-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, micro schema
Equity
€54k▼ 76.7%
2024 · €234k
2021: €62k
2022: €196k
2023: €358k
2024: €234k
2021 → 2025
Total assets
€386k▼ 8.2%
2024 · €420k
2021: €148k
2022: €340k
2023: €538k
2024: €420k
2021 → 2025
Net result
€54k▼ 65.7%
2024 · €158k
2021: €61k
2022: €134k
2023: €162k
2024: €158k
2021 → 2025
Working capital
€-7k
2024 · €81k
2021: €29k
2022: €144k
2023: €197k
2024: €81k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€62k-€196k▲ 218%€358k▲ 83.0%€234k▼ 34.7%€54k▼ 76.7%
Operating result€80k-€183k▲ 129%€221k▲ 21.3%€220k▼ 0.8%€120k▼ 45.4%
Net result€61k-€134k▲ 119%€162k▲ 21.1%€158k▼ 2.9%€54k▼ 65.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 45% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €386k
Fixed assets
€61k ▼ 60.0%
Current assets
€325k ▲ 21.3%
Equity and liabilities €386k
Equity
€54k ▼ 76.7%
Debt
€331k ▲ 77.8%
Debt's share of the balance-sheet total rises from 44.3% to 85.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€123k▼
2024 · €228k
Cash flow
€57k▼
2024 · €166k
Current ratio
0.98▼
2024 · 1.44
Debt to equity
6.09▲
2024 · 0.80
ROE
99.4%▲
2024 · 67.4%
ROA
14.0%▼
2024 · 37.5%
Interest coverage
2.54▼
2024 · 21.02
Debt ≤ 1 year
€331k▲
2024 · €186k
Income taxes
€19k▼
2024 · €53k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€420k€386k▼
Fixed assets21/28€153k€61k▼
Tangible fixed assets22/27€153k€61k▼
Furniture and vehicles24€7k€7k▲
Other tangible fixed assets26€146k€54k▼
Current assets29/58€268k€325k▲
Amounts receivable within one year40/41€27k€46k▲
Trade receivables40€27k€28k▲
Other amounts receivable41-€19k
Cash at bank and in hand54/58€240k€277k▲
Deferred charges and accrued income490/1€1k€2k▲
Equity and liabilities
Total equity and liabilities10/49€420k€386k▼
Equity10/15€234k€54k▼
Contributions10/11€300€300=
Reserves13€234k€54k▼
Distributable reserves133€234k€54k▼
Profit (loss) carried forward14-€0
Amounts payable17/49€186k€331k▲
Amounts payable within one year42/48€186k€331k▲
Trade debts44€2k€3k▲
Suppliers440/4€2k€3k▲
Taxes, remuneration and social security45€32k€10k▼
Taxes450/3€32k€10k▼
Other amounts payable47/48€152k€318k▲
Accrued charges and deferred income492/3€13€0▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€3k▼
Other operating charges640/8€735€1k▲
Non-recurring operating charges66A-€87k
Gross operating margin9900€229k€211k▼
Operating profit (loss)9901€220k€120k▼
Financial income75/76B€2k€1k▼
Recurring financial income75€2k€1k▼
Financial charges65/66B€11k€48k▲
Recurring financial charges65€11k€48k▲
Profit (loss) for the period before taxes9903€211k€73k▼
Income taxes67/77€53k€19k▼
Profit (loss) for the period9904€158k€54k▼
Profit (loss) for the period to be appropriated9905€158k€54k▼
Appropriation of the result
Profit (loss) to be appropriated9906€158k€54k▼
Transfer from equity791/2€282k€234k▼
Transfer to equity691/2€158k€54k▼
To other reserves6921€158k€54k▼
Profit to be distributed694/7€282k€234k▼
Return on contributions (dividend)694€282k€234k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
29-10
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial
Weakest financial yearnet €54k ▼65.7%
Net result drops to €54k, the lowest in the series.
2024
30-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2023
27-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
31-03
Financial
Highest result since 2021net €162k ▲21.1%
Operating result €221k, net result €162k, both a record.
31-03
Financial
Equity above €200kEq €358k ▲83%
3 profitable years in a row build equity to €358k.
2022
07-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 7 days late
31-03
Financial
Equity above €150kEq €196k ▲218%
2 profitable years in a row build equity to €196k.
2021
19-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 19 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oranjerielaan 239030 GentGround area
2,412 m²
Building footprint
219 m²
Volume, LiDAR
1,535 m³
Parcel 44038A0692/00Y000, Flanders · tallest building 9.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ArteMedicale
since 20202.304.895.786
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44038A0692/00Y000 | Flanders | 2,412 m² | 1 · 219 m² | 9.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
254900R6STQ48ILANO07
Similar companies · same sector, comparable size
MASY NADINE
BE 0473.496.293
Halle · Eq €54,582
LIMO KAOLO
BE 0727.764.670
Zaventem · Eq €54,663
LABORAX
BE 0794.339.532
Ath · Eq €54,686
Surgiprint
BE 0778.866.151
Mont-Saint-Guibert · Eq €53,887
DENTAAL LABO DEGRAEVE
BE 1002.966.439
Roeselare · Eq €55,745
Of 698 companies in sector 86910 we hold annual accounts for 520. 263 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-07-2020
Fiscal year end31-03
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
71209Other technical testing and analysis
73200Market research and public opinion polling
74999Other professional, scientific and technical activities
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.